Older drugs with limited trial evidence: Are they worth the expense? The case of repository corticotropin marketed as H.P. Acthar Gel

Ali Duarte-García, Eric L. Matteson, Nilay D. Shah

Research output: Contribution to journalComment/debatepeer-review

3 Scopus citations
Original languageEnglish (US)
Pages (from-to)791-793
Number of pages3
JournalAnnals of internal medicine
Issue number11
StatePublished - 2019

ASJC Scopus subject areas

  • Internal Medicine

Cite this